Become a member today. It's free.
We will not release or resell your information to third-parties without your permission.
Apr 30, 2013 (BUSINESS WIRE) -- Octapharma USA requests that their press release NewsItemId: 20130429006142 issued April 29, 2013, entitled "FDA Accepts Octapharma USA Biological License Application for octaplex(R) - an Investigational 4-Factor PCC" be killed.
The release was issued prematurely by Octapharma USA and contains inaccuracies.